{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:06:01Z","timestamp":1789851961579,"version":"4.0.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012022","name":"Endocrine Society of the Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jfma.2026.08.051","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:52:44Z","timestamp":1788983564000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Taiwan joint consensus on the management of osteoporosis in patients with diabetes"],"prefix":"10.1016","author":[{"given":"Jawl-Shan","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Te","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-3935","authenticated-orcid":false,"given":"Chih-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7642-8060","authenticated-orcid":false,"given":"Der-Sheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Mei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Yih","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.jfma.2026.08.051_bib5","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jfma.2019.06.016","article-title":"Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan","volume":"118","author":"Sheen","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2026.08.051_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00198-025-07443-y","article-title":"Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study","volume":"36","author":"Starup-Linde","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-022-01260-8","article-title":"Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jfma.2026.08.051_bib8","article-title":"Association between type 2 diabetes and osteoporosis risk: a representative cohort study in Taiwan","volume":"16","author":"Lin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2026.08.051_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2024.100330","article-title":"Understanding the impact of diabetes on bone health: a clinical review","volume":"24","author":"Sharma","year":"2024","journal-title":"Metabol Open"},{"key":"10.1016\/j.jfma.2026.08.051_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.051_bib12","article-title":"Advanced glycation end products mediate biomineralization disorder in diabetic bone disease","volume":"5","author":"Gao","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jfma.2026.08.051_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jfma.2026.08.051_bib15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/dme.12734","article-title":"Type 1 diabetes and risk of fracture: meta-analysis and review of the literature","volume":"32","author":"Shah","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/dc07-1072","article-title":"Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2026.08.051_bib18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.2337\/dc13-2957","article-title":"Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies","volume":"37","author":"Liao","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2026.08.051_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.24.7.1198","article-title":"Blue Mountains Eye S. Diabetes and risk of fracture: the Blue Mountains Eye Study","volume":"24","author":"Ivers","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2026.08.051_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S2213-8587(17)30134-1","article-title":"Bone disease in diabetes: another manifestation of microvascular disease?","volume":"5","author":"Shanbhogue","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.051_bib21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/jdi.13542","article-title":"Falls and fractures associated with type 2 diabetic polyneuropathy: a cross-sectional nationwide questionnaire study","volume":"12","author":"Khan","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jfma.2026.08.051_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jamaophthalmol.2017.4983","article-title":"Association between the severity of diabetic retinopathy and falls in an Asian population with diabetes: the Singapore epidemiology of eye diseases study","volume":"135","author":"Gupta","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfma.2026.08.051_bib23","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.2337\/dc26-S004","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2026.08.051_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10916-023-02030-2","article-title":"Artificial intelligence-enabled chest X-ray classifies osteoporosis and identifies mortality risk","volume":"48","author":"Tsai","year":"2024","journal-title":"J Med Syst"},{"key":"10.1016\/j.jfma.2026.08.051_bib25","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.250917","article-title":"Deep learning-based opportunistic CT osteoporosis screening and the establishment of normative values","volume":"317","author":"Westerhoff","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2026.08.051_bib26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00198-024-07179-1","article-title":"Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review","volume":"35","author":"Paderno","year":"2024","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib27","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American association of clinical Endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal Osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2026.08.051_bib30","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jfma.2023.01.007","article-title":"Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update","volume":"122","author":"Tai","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2026.08.051_bib31","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2026.08.051_bib32","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jbmr.3538","article-title":"Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry","volume":"33","author":"Leslie","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib33","article-title":"10-Year fracture risk assessment with novel adjustment (FRAXplus): type 2 diabetic sample-focused analysis","volume":"15","author":"Sima","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jfma.2026.08.051_bib34","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00198-025-07588-w","article-title":"Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study","volume":"36","author":"Zoulakis","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib35","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/GME.0000000000001185","article-title":"Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes","volume":"26","author":"Chen","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.jfma.2026.08.051_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities","volume":"3","author":"Melton","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2214\/AJR.17.17853","article-title":"Prevalence of vertebral compression fractures on routine CT scans according to L1 trabecular attenuation: determining relevant thresholds for opportunistic osteoporosis screening","volume":"209","author":"Graffy","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jfma.2026.08.051_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jbmr.2028","article-title":"Prevalent vertebral fractures on chest CT: higher risk for future hip fracture","volume":"29","author":"Buckens","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00264-016-3146-y","article-title":"Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies","volume":"40","author":"Wang","year":"2016","journal-title":"Int Orthop"},{"key":"10.1016\/j.jfma.2026.08.051_bib43","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1001\/jama.292.23.2890","article-title":"Does this woman have osteoporosis?","volume":"292","author":"Green","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2026.08.051_bib44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.051_bib45","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"Mechanisms IN endocrinology: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.051_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocd.2019.03.004","article-title":"Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific Region","volume":"24","author":"Wu","year":"2021","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jfma.2026.08.051_bib47","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib49","series-title":"Dietary Guidelines for Americans, 2025\u20132030","year":"2026"},{"key":"10.1016\/j.jfma.2026.08.051_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008222","article-title":"A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses","volume":"5","author":"Esposito","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jfma.2026.08.051_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/nu15194255","article-title":"Association of alternative dietary patterns with osteoporosis and fracture risk in older people: a scoping review","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2026.08.051_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11657-025-01588-3","article-title":"The 2024 UK clinical guideline for the prevention and treatment of osteoporosis","volume":"20","author":"Gregson","year":"2025","journal-title":"Arch Osteoporosis"},{"key":"10.1016\/j.jfma.2026.08.051_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bjsports-2021-104634","article-title":"Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis","volume":"56","author":"Brooke-Wavell","year":"2022","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib54","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jbmr.4697","article-title":"Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk","volume":"37","author":"Eastell","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-018-1548-x","article-title":"Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review","volume":"60","author":"Anagnostis","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.jfma.2026.08.051_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","article-title":"Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures","volume":"31","author":"Kanis","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2026.08.051_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186846","article-title":"Osteoporosis in patients with chronic kidney diseases: a systemic review","volume":"21","author":"Hsu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jfma.2026.08.051_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1359\/jbmr.070904","article-title":"Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial","volume":"23","author":"Ensrud","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/jcem.87.1.8168","article-title":"Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial","volume":"87","author":"Andersson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","article-title":"Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00198-022-06616-3","article-title":"Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis","volume":"34","author":"Chen","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib64","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13018-018-0865-3","article-title":"Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis","volume":"13","author":"Wu","year":"2018","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115268","article-title":"Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension","volume":"134","author":"Ferrari","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.jfma.2026.08.051_bib66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21556660.2021.1989194","article-title":"Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis","volume":"10","author":"Pacheco-Soto","year":"2021","journal-title":"J Drug Assess"},{"key":"10.1016\/j.jfma.2026.08.051_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.54734","article-title":"Denosumab and the risk of diabetes in patients treated for osteoporosis","volume":"7","author":"Huang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jfma.2026.08.051_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","article-title":"Teriparatide in patients with osteoporosis and type 2 diabetes","volume":"91","author":"Schwartz","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jfma.2026.08.051_bib70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MED.0000000000000645","article-title":"Treatment of bone fragility in patients with diabetes: antiresorptive versus anabolic?","volume":"28","author":"Shah","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jfma.2026.08.051_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10346","article-title":"Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: a post hoc analysis of the ACTIVE study","volume":"4","author":"Dhaliwal","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/j.jfma.2026.08.051_bib72","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/clinem\/dgae862","article-title":"Romosozumab improves tissue thickness-adjusted trabecular bone score in women with osteoporosis and diabetes","volume":"110","author":"Ferrari","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib73","series-title":"Evenity (romosozumab-aqqg) [prescribing information]","year":"2019"},{"key":"10.1016\/j.jfma.2026.08.051_bib74","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1210\/jc.2018-00163","article-title":"ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis","volume":"103","author":"Bone","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib75","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/jbmr\/zjae116","article-title":"Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension","volume":"39","author":"Cosman","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.afos.2024.02.001","article-title":"Asia-Pacific consensus on long-term and sequential therapy for osteoporosis","volume":"10","author":"Tai","year":"2024","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.jfma.2026.08.051_bib78","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jbmr.2462","article-title":"Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan diabetes cohort Study","volume":"30","author":"Li","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib79","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1463-1326.2012.01583.x","article-title":"Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes","volume":"14","author":"Johnston","year":"2012","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jfma.2026.08.051_bib80","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.2337\/dc26-S013","article-title":"Older adults: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2026.08.051_bib81","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.12998\/wjcc.v8.i18.4010","article-title":"Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus","volume":"8","author":"Wang","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jfma.2026.08.051_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072904","article-title":"Effects of metformin on bone mineral density and bone turnover markers: a systematic review and meta-analysis","volume":"13","author":"Hu","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jfma.2026.08.051_bib83","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-019-04948-1","article-title":"Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"30","author":"Salari-Moghaddam","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/EJE-20-0507","article-title":"Metformin use is associated with a lower risk of osteoporosis\/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus","volume":"184","author":"Tseng","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.051_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101455","article-title":"Meta-analysis on the association between DPP-4 inhibitors and bone mineral density and osteoporosis","volume":"27","author":"Huang","year":"2024","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jfma.2026.08.051_bib86","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","article-title":"Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials","volume":"34","author":"Monami","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2026.08.051_bib87","doi-asserted-by":"crossref","DOI":"10.2174\/0127724328373328250624065307","article-title":"Dipeptidyl Peptidase-4 inhibitors and the risk of fractures in type 2 diabetes mellitus patients: a bayesian network meta-analysis","author":"Ahmad","year":"2025","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"10.1016\/j.jfma.2026.08.051_bib88","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00592-025-02468-5","article-title":"Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis","volume":"62","author":"Tan","year":"2025","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jfma.2026.08.051_bib89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11914-025-00937-y","article-title":"Headline: fracture risk in type 2 diabetes: systematic review of cardiovascular outcome trials with Glucagon like peptide receptor agonists","volume":"23","author":"Mahalingasivam","year":"2025","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jfma.2026.08.051_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112995","article-title":"Association of tirzepatide use with risk of osteoporosis compared with other GLP-1 receptor agonists: a retrospective cohort study using the TriNetX database","volume":"230","author":"Hsu","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jfma.2026.08.051_bib91","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jbmr\/zjaf135","article-title":"Effects of weight-loss interventions on bone health in people living with obesity","volume":"40","author":"Paccou","year":"2025","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2026.08.051_bib92","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP15758.OR","article-title":"Comparison of the long-term effects of liraglutide and glimepiride monotherapy on bone mineral density in patients with type 2 diabetes","volume":"22","author":"Gilbert","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jfma.2026.08.051_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107990","article-title":"Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis","volume":"159","author":"Zhang","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jfma.2026.08.051_bib94","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/jc.2007-2249","article-title":"Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"93","author":"Glintborg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib95","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial","volume":"92","author":"Grey","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib96","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib97","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jfma.2026.08.051_bib98","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib99","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00125-019-4955-5","article-title":"Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program","volume":"62","author":"Zhou","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jfma.2026.08.051_bib100","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib102","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.051_bib104","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00198-023-06908-2","article-title":"Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"34","author":"Wang","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30762","article-title":"Association of sodium-glucose Cotransporter-2 inhibitors with fracture risk in older adults with type 2 diabetes","volume":"4","author":"Zhuo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jfma.2026.08.051_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101465","article-title":"Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: a nationwide retrospective cohort study","volume":"49","author":"Peng","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jfma.2026.08.051_bib107","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00198-017-4276-9","article-title":"The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study","volume":"29","author":"Ruppert","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib108","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41598-017-03748-z","article-title":"Insulin use and excess fracture risk in patients with type 2 diabetes: a propensity-matched cohort analysis","volume":"7","author":"Losada-Grande","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2026.08.051_bib109","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2026.08.051_bib110","doi-asserted-by":"crossref","DOI":"10.1007\/s40266-026-01290-0","article-title":"Managing bone fragility in older adults with diabetes: pathophysiology, assessment, and therapeutic considerations","author":"Bahat","year":"2026","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jfma.2026.08.051_bib111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11657-024-01399-y","article-title":"Evaluating compliance with the care standard of proactively assessing bone health in patients with diabetes: a pilot audit of practice across Asia by the Asia Pacific Consortium on Osteoporosis (APCO)","volume":"19","author":"Chandran","year":"2024","journal-title":"Arch Osteoporosis"},{"key":"10.1016\/j.jfma.2026.08.051_bib112","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1532-5415.2005.00618.x","article-title":"Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial","volume":"54","author":"Feldstein","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2026.08.051_bib113","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00198-022-06524-6","article-title":"Perceptions of fracture and fall risk and of the benefits and barriers to exercise in adults with diabetes","volume":"33","author":"Drummond","year":"2022","journal-title":"Osteoporos Int"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626008405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626008405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:51:42Z","timestamp":1789851102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626008405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":106,"alternative-id":["S0929664626008405"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.051","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taiwan joint consensus on the management of osteoporosis in patients with diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}